Exploiting Acquired Drug Resistance in Pancreatic Cancer through Selective Covalent Targeting of MAP2K4/7
Year: 2026
Type: article
Source: ACS Chemical Biology
Institutions: Northwestern University, Osaka Metropolitan University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7210273443
